The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas.
High-grade bone sarcoma
Magnetic resonance imaging
Sarcoma
Skip metastases
Journal
Skeletal radiology
ISSN: 1432-2161
Titre abrégé: Skeletal Radiol
Pays: Germany
ID NLM: 7701953
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
07
08
2019
accepted:
29
12
2019
revised:
21
12
2019
pubmed:
11
1
2020
medline:
9
2
2021
entrez:
11
1
2020
Statut:
ppublish
Résumé
Skip metastases have been described with osteosarcoma, Ewing sarcoma and rarely chondrosarcoma. The aim of this study was to determine the incidence of skip metastases on whole bone MRI in all primary high-grade sarcomas of the major long bones. Retrospective review of patients from April 2007 to April 2019 with high-grade primary bone sarcomas of the humerus, radius, ulna, femur, tibia or fibula who had whole bone MRI at initial staging. Data collected included age, sex, tumour type, presence and location of skip metastases based on whole bone MRI and presence of distant metastases (the skeleton and lung). The study included 216 males and 171 females with mean age 30.6 years (range 4-92 years). Tumour types were as follows: High-grade osteosarcoma n = 202, Ewing sarcoma n = 68, high-grade chondrosarcoma n = 44, dedifferentiated chondrosarcoma n = 37, high-grade spindle cell sarcoma n = 29 and angiosarcoma n = 7. Skip lesions were identified in 63 (16.3%). However, after taking into account the presence of distant skeletal (n = 11) and pulmonary (n = 33) metastases, the overall incidence of skip metastases was 6.5%, occurring in 15 (7.5%) high-grade osteosarcomas, 3 (4.5%) Ewing sarcoma, 1 (2.8%) high-grade chondrosarcoma, 4 (10.8%) dedifferentiated chondrosarcomas, and 2 (6.9%) high-grade spindle cell sarcomas. A false positive MRI diagnosis of skip metastasis was made in 4 cases, 3 enchondromata and one focal nodular marrow hyperplasia. The current study has documented the incidence of skip metastases in common types of high-grade primary bone sarcoma. The possibility of false positive skip metastases has also been highlighted.
Identifiants
pubmed: 31919587
doi: 10.1007/s00256-019-03369-9
pii: 10.1007/s00256-019-03369-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
945-954Références
J Clin Oncol. 2006 Apr 1;24(10):1535-41
pubmed: 16575004
J Nucl Med. 2003 Jun;44(6):930-42
pubmed: 12791822
J Bone Joint Surg Am. 1990 Jan;72(1):60-8
pubmed: 2295674
Cancer. 1975 Dec;36(6):2192-205
pubmed: 1060507
AJR Am J Roentgenol. 2008 Jun;190(6):1611-5
pubmed: 18492914
Clin Radiol. 2017 Mar;72(3):265.e7-265.e23
pubmed: 27889090
Skeletal Radiol. 2019 Apr;48(4):503-516
pubmed: 30288560
Clin Orthop Relat Res. 2004 Sep;(426):92-6
pubmed: 15346057
Insights Imaging. 2014 Aug;5(4):419-40
pubmed: 25005774
PLoS One. 2017 Mar 16;12(3):e0173665
pubmed: 28301537
Pediatr Blood Cancer. 2016 Aug;63(8):1381-6
pubmed: 27082077
Skeletal Radiol. 1997 Jun;26(6):379-84
pubmed: 9229423
Australas Radiol. 1995 Aug;39(3):303-5
pubmed: 7487772
Clin Orthop Relat Res. 1996 Jul;(328):211-9
pubmed: 8653959
Clin Imaging. 2011 Sep-Oct;35(5):378-84
pubmed: 21872128
J Bone Joint Surg Br. 2011 Sep;93(9):1271-8
pubmed: 21911541
J Surg Oncol. 2017 Aug;116(2):252-257
pubmed: 28420036
Eur J Cancer. 2007 Sep;43(14):2060-5
pubmed: 17720491
Am J Clin Oncol. 2014 Dec;37(6):528-34
pubmed: 23466575
Skeletal Radiol. 2019 Dec;48(12):1861-1874
pubmed: 31309243
Acta Orthop. 2005 Dec;76(6):899-903
pubmed: 16470449
Cancer. 2006 Jun 15;106(12):2682-91
pubmed: 16691621
Clin Orthop Relat Res. 1975 Sep;(111):33-41
pubmed: 1057464
Rare Tumors. 2013 Sep 17;5(3):e53
pubmed: 24179665